Bluu Biosciences Revenue and Competitors

Berlin, Germany

Location

#7715

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Bluu Biosciences's estimated annual revenue is currently $10.8M per year.(i)
  • Bluu Biosciences's estimated revenue per employee is $169,531

Employee Data

  • Bluu Biosciences has 64 Employees.(i)
  • Bluu Biosciences grew their employee count by 8% last year.

Bluu Biosciences's People

NameTitleEmail/Phone
1
Chief Technology OfficerReveal Email/Phone
2
CEOReveal Email/Phone
3
Head Food TechnologyReveal Email/Phone
4
VP Finance & AdministrationReveal Email/Phone
5
Associate Director Cell Culture and Media DevelopmentReveal Email/Phone
6
Business Development ManagerReveal Email/Phone
7
Office-ManagerReveal Email/Phone
8
Quality and Regulatory ManagerReveal Email/Phone
9
Food Product DeveloperReveal Email/Phone
10
Research AssistentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.9M27721%N/AN/A
#2
$33.7M174-10%$521.9MN/A
#3
$52.4M32116%N/AN/A
#4
$162.7M121933%N/AN/A
#5
$43.2M2797%N/AN/A
#6
$1.1M7N/AN/AN/A
#7
$24.2M21339%N/AN/A
#8
$19.7M11713%N/AN/A
#9
$21.2M81-12%$347.1MN/A
#10
$18.3M1187%$197.4MN/A
Add Company

What Is Bluu Biosciences?

Creating the future of healthy seafood — made from fish cells.

keywords:N/A

N/A

Total Funding

64

Number of Employees

$10.8M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bluu Biosciences News

2022-04-06 - Bluu Seafood and CellX Partner to "Make Cellular Agriculture ...

Bluu Seafood (formerly Bluu Biosciences), which claims to be the first European company specializing in cultivated fish, will present its...

2022-04-06 - Bluu Seafood And CellX Announce Cross-Continental ...

Bluu Seafood, formerly Bluu Biosciences, is the first European startup to be exclusively targeting cultivated fish. The company aims to have...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.6M6410%N/A
#2
$8.4M64N/AN/A
#3
$8.1M6425%N/A
#4
$24.6M64-44%N/A
#5
$8.6M6425%N/A